ARCHIVES

Toxicity Of Salts Regimen Should Remain A Concern.

This article is from The Cancer Letter archive.

Vol. 28 No. 01 | January 4, 2002

Download PDF Visit The Full Archive

Related Articles

EPO Controversy: ODAC To Review EPO Agents in May; SEC Probes Amgen’s Delay in Study Disclosure.

March 2, 2007

DeVita, Moertel Debate Timing Of Levamisole Update

February 16, 1990

GAO Criticize NCI Contract Practices In Report On Cancer Control

July 25, 1980

Ohio State, Hawaii Name New Center Directors; Berlin Acting Director At Papanicolaou

July 29, 1988

DCE Board Approves Concepts For Three New RFA Programs

July 6, 1984

CMS Issues Coverage Decision For Provenge in Prostate Cancer

July 29, 2011